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Optimal sparse solution for fluorescent diffuse optical
tomography: theory and phantom experimental results
Pouyan Mohajerani, Ali A. Eftekhar, Jiandong Huang, and Ali Adibi
We present a method to accurately localize small fluorescent objects within the tissue using fluorescent
diffuse optical tomography (FDOT). The proposed method exploits the localized or sparse nature of the
fluorophores in the tissue as a priori information to considerably improve the accuracy of the reconstruc-
tion of fluorophore distribution. This is accomplished by minimizing a cost function that includes the L1
norm of the fluorophore distribution vector. Experimental results for a milk-based phantom using a
fiber-based cw FDOT system demonstrate the capability of this method in accurately localizing small
fluorescent objects deep in the phantom. © 2007 Optical Society of America
OCIS codes: 170.3010, 170.0170, 170.3880, 170.7050.
1. Introduction
Biological tissue is known to have low optical ab-
sorption in the near-infrared (NIR) bandwidth 700–
900 nm; a property that has enabled a variety of NIR
imaging techniques. Diffuse optical tomography (DOT)
is a widely used method to deliver images of the optical
scattering and absorption properties deep inside the
tissue.1–3 These optical properties in turn are corre-
lated with the biological properties of the tissue.
In a typical DOT setup, the tissue is pumped with
NIR light transmitted through a multiple-mode fiber,
called the source fiber, which is placed on the surface of
the tissue. The light scattered off the surface is then
collected at different positions with many multiple-
mode fibers, called detect fibers, which are connected
to the optical detection devices on the other end. The
propagation of light from the source fiber in the tissue
can be described by a forward problem. The optical
properties of the tissue are estimated by solving the
inverse problem using the measurements. Two main
technical challenges in DOT are the ill-posedness of
the inverse problem and the relatively modest contrast
between the optical properties of healthy and abnor-
mal tissues.1 The former problem can be mitigated
utilizing a priori information about the optical proper-
ties of the tissue under investigation. Such information
is often obtained from other imaging techniques, such
as magnetic resonance imaging (MRI) and x-ray im-
aging.4
The low contrast between healthy and abnormal
tissues can be increased by the administration of fluo-
rescent contrast agents and molecular probes that
target specific cells.5–8 Fluorescent diffuse optical to-
mography (FDOT) seeks to estimate the spatial dis-
tribution of the concentration or lifetime of exogenous
and endogenous fluorophores in tissue using surface
optical measurements9–16 and has diverse applica-
tions such as early cancer detection17,18 and monitor-
ing and optimization of photodynamic therapy.19 The
fluorescent contrast agents are often localized in cer-
tain areas of interest, e.g., cancerous lesions, rather
than smoothly distributed within the tissue. Local-
ization of such fluorescent objects embedded in phan-
toms and tissues has been the subject of many
studies.20–26 Detection of small isolated objects in
bulk tissue, deemed as a “stumbling block” of optical
methods for tumor detection,27 can be specially im-
proved using such target-specific contrast agents.
Here we show how the localized pattern, or sparse-
ness, of fluorophores in tissues can be exploited as
a priori information to improve the resolution of FDOT
systems. The proposed method relies on a small num-
ber of measurements to rapidly localize small fluo-
rescent objects in a large volume of highly scattering
tissue. The main underlying assumption is that the
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fluorophores are localized in small volumes or, in
other words, in a sparse pattern. This is specially the
case in the early stages of cancer where the size of
cancerous tumors tagged with the fluorescent probes
is small compared with the resolution of DOT.
The work presented in this paper is developed in
the context of frequency-domain FDOT.28,29 Using
a milk-based phantom, experimental results are ob-
tained from a fiber-based cw FDOT system. The pro-
posed approach is able to effectively reconstruct the
two small fluorescent objects used in this experiment.
The result of a conventional reconstruction method is
also presented for comparison purposes.
We first present the mathematical framework of
FDOT in Section 2. In Section 3 we present our ap-
proach for solving the inverse problem in FDOT
based on the sparseness of the fluorophore distribu-
tion. The design and technical details of our FDOT
system are discussed in Section 4. The experimental
results are presented in Section 5, and Section 6 con-
tains a discussion about the advantages and short-
comings of the presented approach. Final conclusions
are summarized in Section 7.
2. System Modeling of Fluorescent Diffuse Optical
Tomography
The problem of finding the fluorophore distribution
within the tissue (i.e., the inverse problem) based on
emission measurements, can be modeled as a linear
problem. As the first step in establishing such a re-
lation, we need to model the propagation of the exci-
tation (or pump) light and the emission light in the
tissue, or in other words, solve the forward problem.
The propagation of light in tissue is governed by the
radiative transfer equation that can be approximated
by the diffusion approximation (DA).1 The boundary
conditions required to solve the equations formed by
the DA are determined based on the medium neigh-
boring the tissue. The two main types of surrounding
media are air and perfectly absorbing medium. The
Robin boundary condition is used for tissue–air in-
terfaces and the light fluence is forced to zero where
tissue is surrounded by a perfectly absorbing medi-
um.30 The finite-element method (FEM) is usually
the method of choice for solving the equations formed
by the DA.31
We are concerned with estimating the fluorophore
distribution in the tissue (or phantom) and not the
spatial distribution of the optical properties. There-
fore, we assume these optical properties are known
a priori. Estimations of the optical properties of the
tissue can be obtained using various DOT techniques
prior to FDOT measurements.9
The fluorophore distribution in the tissue can be
represented by a K  1 vector X, where K is the
number of nodes in the 3D FEM mesh. Each element
of X denotes the fluorophore concentration on the
corresponding mesh node. The relationship between
X and the optical measurements gathered on the sur-
face of the tissue can be derived in a few steps.
First, we introduce the FEM formulation describing
the propagation of the excitation light and the emis-
sion light in the tissue. Let Ns and Nd denote the
number of source and detector fibers placed on the
tissue surface. The relation between fluences and








i ei and Qmi Qei are fluence and source
vectors at the emission (excitation) wavelength, re-
spectively, when the ith source fiber is used. Here we
assume that only one source fiber is excited at a time.
The complex matrix Km Ke is the stiffness matrix
obtained from the FEM formulation at the emission
(excitation) wavelength.9 The excitation source vec-
tor, Qe
i, is nonzero only on the mesh nodes that neigh-
bor the ith source fiber. The emission source vector,
Qm
i, is derived as follows. Note that each mesh node
acts as a light source at the emission wavelength. The
K  1 vector, Qm
i, represents the intensities of these
sources. This vector, as seen in Eq. (2), is actually
the source vector in the FEM formulation of the for-
ward problem at the emission wavelength. The inten-
sity of each mesh node as a fluorescent source is
clearly equal to the concentration of fluorophores on
that node multiplied by the amount of excitation light
that reaches that node, namely, the excitation fluence
at that node. Therefore we have
Qm
i  diageiX, (3)
where for any K  1 vector g, diagg is defined as a
K  K diagonal matrix V with the elements of V as its
main diagonal elements. Furthermore, we need to
describe the measurements in terms of the FEM
model parameters. Let M i be an Nd  1 complex
vector representing the emission measurements at
all detector fibers when the tissue is excited by the ith
source fiber. Generally, we can write
Mi  Cm
i, (4)
where C is an Nd  K real matrix describing measure-
ments obtained on each detector fiber as a linear com-
bination of the fluences of its neighboring nodes.32
The last step in establishing the relation between
measurements M and the desired unknown vector X
involves inserting Eqs. (1), (2), and (3) into Eq. (4),
which results in a set of Ns equations:
Mi  CKm
1 diagKe1QeiX. (5)
Stacking all the measurements for all the sources in
an NsNd  1 column vector M yields the following
linear equation:
M  ZX  F, (6)
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where F is a complex NsNd  1 column vector repre-










Equation (6) is the final equation that relates the
unknown fluorophore distribution X to the measure-
ments M. Note that we do not need to actually carry
matrix inversions in Eqs. (5) and (7). Instead, we use
Gaussian elimination, which significantly reduces
the computational complexity. The inverse problem
of FDOT consists of solving Eq. (6) for X given M
and Z. It should be noted that, as the number of
FEM nodes is often much more than the number of
measurements, Eq. (6) is a highly underdetermined
problem.
3. Proposed Approach
A. Sparse Solutions to Underdetermined Linear Problems
The problem of finding the sparsest solution, namely,
one with the smallest number of nonzero elements, to
an underdetermined problem is an interesting one
with diverse applications. A powerful mathematical
fact is that, under certain conditions, the solution
with the minimum L1 norm is often the sparsest so-
lution as well.33 The L1 and L2 norms of an arbitrary
vector v, with elements vi, are denoted as v1 and
v2, respectively, and defined as v1  |vi| and
v2  vi212. To clarify the rationale behind
this fact, consider the simple case of a linear equation
with two unknowns. Specifically, suppose we want to
find the sparsest solution of the equation 1.5x1  x2
 1. Figure 1 shows the solution line that includes
all the possible solutions of this equation. The dot-
ted lines and the dotted circles in Fig. 1 denote the
contours of functions l1x1, x2  |x1|  |x2| and
l2x1, x2  x12  x2212, respectively, i.e., the contours
of points with constant L1 and L2 norms.
For this example, the solution with the least L1
norm can be found by finding the closest dotted line to
the origin that crosses the solution line, which is
point A in Fig. 1. As seen, point A lies on the x1 axis.
This means that the solution with the least L1 norm
has only one nonzero element, i.e., is the sparsest.
Point B in Fig. 1 is the solution with the least L2
norm, which is obviously not sparse.
B. Sparseness of Fluorophore Distribution and the Effect
of Background Fluorescence
The fluorescent objects formed in the tissue through
selective uptake of probe fluorophores are often fairly
small. For example, when tagged with fluorescent
probes, the tumors in the early stage of cancer can
form fluorescent objects as small as 0.5 cm3.21 These
small fluorescent objects are often modeled as fluo-
rescent point sources within the tissue.22,34 Reference
35 employs an FDOT system with reflection geometry
to verify that a point-source model often sufficiently
represents tumors smaller than 1 cm3 in size, as the
optical measurements obtained for tumors with dif-
ferent sizes (0.2 to 1 cm in diameter) show similar
intensity profiles.
Background fluorescence is often present because
of the exogenous fluorophores not uptaken by tar-
geted lesions and the autofluorescence of tissue.36
The effect of such background emission on the mea-
surements, even for high uptake ratios, can be sig-
nificant.34 Various methods have been proposed for
removal or subtraction of the background fluores-
cence prior to the processing of the FDOT measure-
ments.36,37 Other approaches account for background
fluorescence by applying bound constraints on the
fluorophore concentration values in the optimization
algorithm.38 Removal of the background fluorescence
often results in the perfect uptake scenario,11 where
the fluorophores are assumed to exist only in the
fluorescent inclusions.
We first obtain an estimate of the background fluo-
rescence as described in Section 4 and then subtract
it from the emission measurements. Therefore, we
can assume perfect or very high uptake of fluoro-
phores by targeted lesions. This assumption, together
with the fact that the fluorescent inclusions are gen-
erally small, implies that only a few elements of vec-
tor X have significant values and the rest are either
zero or have a minor effect on the measurements. In
other words, fluorophore distribution X can be rea-
sonably considered sparse when the fluorophores are
mainly concentrated in small lesions and the back-
ground fluorescence is largely removed.
Finally, since the autofluorescence emission is gen-
erally distributed smoothly over the tissue volume, it
can be modeled with few parameters that can be
added to the problem unknowns.36 Such modeling of
the autofluorescence preserves the sparseness of the
unknown vector. The details of this method for back-
ground emission reduction will be presented else-
where.39
Fig. 1. Solution line for equation 1.5x1  x2  1 and contours of
the L1 and L2 norms. Points A and B denote the points on the
solution line (solid line) with minimum L1 and L2 norms, respec-
tively. Point A is the sparsest solution, as it has only one nonzero
coordinate, and point B is not a sparse solution, since all its coor-
dinates are nonzero.
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C. Proposed Approach Toward the Inverse Problem in
Fluorescent Diffuse Optical Tomography
We demonstrate our approach for finding the spars-
est solution to the inverse problem in FDOT, using
the idea discussed in Subsection 3.A. We achieve this
by minimizing a cost function based on the weighted
addition of the L1 norm of the solution and the mis-
match between the measurements and the system
model. Specifically, the desired solution, X1, can be
written as
X1  arg min
X0
	f1X  M  ZX22  X1
, (8)
where  is the weighting constant balancing the
weight of the two contributing terms. We assume the
measurement noise in the system can be modeled
by a vector of independent identically distributed
Gaussian variables, and therefore do not apply any
weighting to the data fidelity term in Eq. (8). In a
system limited by the detector shot noise, the data
fidelity term should be properly weighted by the in-
verse of the noise covariance matrix.9 Note that the
nonnegativity constraint is imposed as the fluoro-
phore concentration cannot be negative. The convex
cost function, f1, can be minimized using various con-
vex optimization techniques. Also, due to the positiv-
ity constraint, we can replace X 1 by i Xi in Eq. (8)
and arrive at a differentiable and convex cost func-
tion that can be minimized using quadratic program-
ming techniques. A preconditioning method is used to
improve the performance of the above approach by
normalizing the columns of matrix Z defined in Eq.
(7). This normalization compensates for the low level
of emission light coming from nodes deep in the tis-
sue. Specifically, we used a diagonal matrix W, de-
fined in Eq. (11), to normalize each column of matrix
Z to norm 1. The resultant preconditioned system
matrix is therefore given as ZW. The preconditioned
problem is rewritten as
X1  WY1, (9)
Y1  arg min
Y	0
	f1Y  M  ZWY22  Y1
, (10)
Wi, j Zi21 i  j0 i 
 j, i, j  1, . . . , K, (11)
where Zi is the ith column of Z.
4. Fluorescent Diffuse Optical Tomography
Experimental Setup
We delineate the design and specifications of our cw
FDOT system to verify our theoretical approach. Since
a cw FDOT system is a special case of frequency-
domain FDOT systems, the formulations and methods
presented so far are applicable here as well. The sche-
matic of this system is depicted in Fig. 2. The phantom
used in the experiment consists of a cylinder with a
diameter of 7.5 cm and height of 6 cm, which is filled
with a milk-based solution. The interior of the cyl-
inder is painted black to realize a perfectly absorb-
ing boundary condition.30 The top surface of the
cylinder is open and in direct contact with air. The
cylinder is filled with diluted milk and Indian ink
solution. Milk is known to have similar scattering
properties as tissue and the Indian ink is added to
increase the absorption of the solution.40 Both detec-
tor and source fibers are placed on the top surface of
the phantom. This measurement geometry (reflection
geometry) is used to emulate real measurements on
tissue where only one side of the tissue is accessible for
measurement, such as in breast imaging. The phan-
tom is assumed to have homogeneous optical proper-
ties.
Small glass cuvettes filled with Rhodamine 6G (dis-
solved in methanol), used as small fluorescent objects,
are fixed inside the liquid phantom using very thin
metallic strings. The effect of these metallic strings on
light propagation in the phantom is negligible. To im-
prove the signal-to-noise ratio (SNR) of measurements,
we employ the lock-in technique in our experiments. A
cw solid-state laser source at wavelength 532 nm is
modulated by a mechanical chopper at a frequency of
2 kHz and is coupled into a 600 m core multiple-
mode fiber using a 40 objective lens. Note that al-
though a clinical DOT system would usually use a
NIR laser source (as the blood hemoglobin makes the
tissue highly absorbing in shorter wavelengths),1 the
use of Rhodamine 6G as a visible wavelength dye is
optional for experimental verification due to its high
quantum yield.11 However, the optical characteristics
of the phantom (i.e., scattering and absorption cross
section) at 532 nm are similar to those of the real
tissue at NIR wavelength. Furthermore, since the
modulation frequency is very small, the system be-
haves essentially like a cw DOT system.
The excitation light is delivered to the surface of the
liquid phantom using the multimode source fiber. This
light excites the fluorophores in the phantom. The ex-
Fig. 2. Schematic of the fiber-based cw FDOT setup. The surface
measurements are collected via the multimode fiber and detected
using the PMT after going through a filter to separate the emitted
light from the excitation (pump) light. The lock-in technique allows
for a high SNR in the emission measurements.
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citation light and the emission light are collected at the
liquid surface using a multimode detector fiber with
a core diameter of 600 m. The detector fiber is at-
tached to a computer-controlled rotation stage, which
scans the detector fiber around a circle across the top
surface of the phantom. The measurements are taken
on a set of equally spaced angles around this circle.
The excitation light and the emission light col-
lected by the detector fiber are separated using two
bandpass filters mounted on a filter wheel, as shown
in Fig. 2. A Hamamatsu H8249-101 photomultiplier
tube (PMT) module is used as the detector and the
output of the PMT is connected to the input port of
the lock-in amplifier, which measures the relative
intensity and phase shift of the detected signal. Due
to the very low modulation frequency of this experi-
ment, the phase of the detected signal has very small
variations for different positions of the detector fiber.
The signal detected using the lock-in amplifier has a
much higher SNR than the signal detected by direct
power measurement. A general-purpose interface bus
module is used to acquire data from the lock-in ampli-
fier and control the rotation stage. The measurements
obtained from the lock-in amplifier are then used to
find the fluorophore distribution within the tissue us-
ing the approach presented in Subsection 3.C. The
phantom shows significant background emission due
to the autofluorescence of milk.41 As suggested in
Subsection 3.B, we adopt a subtraction scheme to
remove the autofluorescence of the phantom from the
measurements prior to processing. We remove the
autofluorescence signal in a differential manner.
That is, we first obtain emission measurements of the
phantom before the insertion of fluorescent objects
and then subtract them from the measurements ac-
quired after insertions of the objects.
We use the method proposed in Ref. 42 for measur-
ing the absorption coefficient a and the scattering
coefficient s of the phantom solution. In this
method, infinite medium measurements (emulated
using a large tank) are used to estimate a and s of
the solution for different concentrations of milk and
ink. The absorption coefficient of ink is obtained us-
ing the transmission method (assuming negligible
scattering for ink).
5. Experimental Results
The cw DOT system described above is used to
experimentally observe and validate the merit of
the approach presented in Subsection 3.C. Figure 3
shows the configuration of this experiment. The large
cylinder represents the cylinder that is filled with
diluted milk and India ink solution (as described in
Section 4). Two small glass cuvettes with approxi-
mate dimensions of 1 mm  1 mm  3 mm filled with
Rhodamine 6G are placed inside the liquid phantom
at locations marked with squares in Fig. 3. The two
glass cuvettes are placed 1 cm under the phantom
surface and are approximately 2 cm apart. The dye
solution has a concentration of 417 M, therefore,
each cuvette contains approximately 1.25 nmol of
Rhodamine 6G. The phantom is a 260 ml solution of
25% water and 75% whole milk. India ink (waterproof
drawing ink from Higgins) with a concentration of
12.5 ppm is added to the solution to increase absorp-
tion. The optical properties, a and s, of this solution
are estimated at both the excitation wavelength
532 nm and the emission bandwidth 580–620 nm,
as described in Section 4, and are presented in
Table 1. The source and detector fibers are placed at
the top circle of the cylinder and measurements are
acquired for 30 equally spaced angles, as shown in
Fig. 3. To calculate the forward model for the phan-
tom, a 3D FEM mesh of 33,750 nodes and 186,345
tetrahedral elements is used to discretize the phan-
tom volume. The emission light and the excitation
light are separated using two bandpass filters. A con-
vex optimization technique is used to solve the inverse
problem. To reduce the computational complexity, the
optimization domain is limited to a smaller cylinder
with a height of 1 cm, shown as the upper portion of the
larger cylinder in Fig. 3.
To calculate the distribution of the fluorophores
the inverse problem is solved using the approach
presented in Subsection 3.C. Figure 4(a) shows the
fluorophore distribution estimated from the emis-
sion measurements using the proposed method. The
fluorophore distribution is depicted using horizontal
cross sections at different z coordinates for 1.5 cm
Fig. 3. Configuration of the experiment. The large cylinder de-
notes the phantom. The source position and detector positions
are depicted on the top of the phantom. Two squares show the
locations of the small fluorescent objects (i.e., cuvettes). The
smaller cylinder shown as the upper portion of the phantom
depicts the optimization domain for which the inverse problem is
solved.












Excitation (532 nm) 0.0088 20.06 0.035
Emission (580–620 nm) 0.0083 12.15 0.033
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 z  2.5 cm, where the estimated distribution has
nonzero values. The proposed method has been able
to find the positions of the two fluorescent cuvettes
(as seen in the cross sections with the corresponding
z coordinates) with fairly good accuracy. For compar-
ison purposes, we also used a conventional method
based on the Tikhonov regularizer26 for solving the
inverse problem. The solution obtained using the
Tikhonov-based method is shown in Fig. 4(b). As
seen, the solution is expectedly highly spread out
along the three spatial coordinates.
6. Discussion
Localization of the fluorescent probes in a large tissue
is a challenging problem due to a very large degree of
freedom (DOF), i.e., the number of unknown variables.
The large number of independent measurements re-
quired for this task implies a long acquisition time. In
many cases, such localization may even be impossible
due to the restricted and ill-posed measurement geom-
etry. The method proposed in this paper takes advan-
tage of the sparseness of the fluorophore distribution to
localize isolated fluorescent objects in the tissue using
a small set of measurements. There is an upper limit
on the maximum number of fluorescent objects in the
tissue that can be resolved properly using this method.
This upper limit is a function of the total number of
measurements and the DOF (a lower bound for this
limit is discussed in Ref. 31 for a general linear prob-
lem). We have considered a sparse model for the dis-
tribution of fluorophores in tissue. This assumption is
justified in many important cases where the targeted
regions form small fluorescent objects (with sizes of
the order of 0.5 cm3) when tagged with fluorescent
probes. However, there are clearly situations where
the size of the fluorescent inclusions in tissue is too
large to fit a sparse model, for example, as in the case
of metastatic spread of cancer (though Ref. 19 argues
that these metastatic lesions can also be mimicked by
multiple small targets).
The main optimization problem in both the con-
ventional and our method is based on a convex cost
function. A nonnegative convex optimization tech-
nique can therefore be used to find the optimal solu-
tion for both methods. However, since the Hessian
matrix of the cost function in the proposed method is
only semipositive definite and not absolutely positive
definite, the optimization has a slightly higher compu-
tation cost compared to the Tikhonov-based approach
where the Hessian matrix of the cost function is posi-
tive definite. To assure the convergence of the convex
optimizer in a reasonable time, we need to maintain a
low DOF. We have reduced the DOF by limiting the
optimization domain to a portion of the whole tissue.
Furthermore, we use a fine mesh for solving the for-
ward problem and a courser mesh with a fewer num-
ber of nodes for the inverse problem. The number of
optimization DOFs used in this work is 5381.
As observed, an accurate solution is obtained by as
low as 60 measurements. Since all these measure-
ments are obtained for only two source positions, the
measurements can be potentially accomplished in two
single-shot acquisitions, allowing a very low data ac-
quisition time. It should also be mentioned that, al-
though our experimental results are presented for a cw
FDOT system at 532 nm, results are easily extend-
able for NIR FDOT systems working at high modu-
lation frequencies.
7. Conclusion
We have presented a new approach to fluorescent dif-
fuse optical tomography based on a sparse model for
distribution of the fluorescent probes in the tissue with
considerably better accuracy than the conventional
technique. Utilizing the sparse model of fluorophore
distribution and minimizing its L1 norm enable the
FDOT systems to gain higher spatial resolution with
a smaller number of measurements. The experimen-
tal results on tissue phantom agree with the theory
and verify the effectiveness of the proposed method
and its advantage over the conventional method.
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